A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor.

J Biol Chem

Department of Pharmacology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

Published: May 1994

The beta-adrenergic receptor kinase (beta ARK) specifically phosphorylates the activated form of the beta 2-adrenergic receptor (beta 2AR) and related G protein-coupled receptors. To further elucidate the role of beta ARK in receptor desensitization, we generated a beta ARK dominant negative mutant by converting an invariant lysine residue in the protein kinase catalytic domain to an arginine. Expressed and purified beta ARK-K220R was able to inhibit wild type beta ARK phosphorylation of the beta 2AR in vitro. When stably transfected into human bronchial epithelial BEAS-2B cells, beta ARK-K220R promoted a > 2-fold increase in beta-agonist-stimulated cAMP production without affecting beta 2AR sequestration. In contrast, beta ARK-K220R had no effect on the desensitization of the prostaglandin E2 receptor response in BEAS-2B cells. These findings directly demonstrate a role for beta ARK in desensitization of the beta 2AR in intact cells and establish the potential utility of using dominant negative mutants to elucidate the substrate specificity of G protein-coupled receptor kinases.

Download full-text PDF

Source

Publication Analysis

Top Keywords

beta ark
20
beta 2ar
16
beta
14
dominant negative
12
beta ark-k220r
12
beta-adrenergic receptor
8
receptor kinase
8
negative mutant
8
desensitization beta
8
beta 2-adrenergic
8

Similar Publications

Background: Immunization against influenza and respiratory syncytial virus (RSV) protects pregnant individuals and their infants against infection via transplacental transport of immunoglobulin G (IgG). We sought to evaluate the quantity and efficiency of maternal influenza- and RSV-specific IgG transfer in pregnancies with preterm and full-term deliveries.

Methods: Delivery samples from 115 maternal-infant pairs (2018-2021) were analyzed for RSV prefusion F and IAV-H3 and IAV-H1 antibodies using electrochemiluminescence assays.

View Article and Find Full Text PDF

In light of the ponderomotive force, this article focuses on establishing the exact wave structures of the ion sound system. It is the result of non-linear force and affects a charged particle oscillating in an inhomogeneous electromagnetic field. By using the Riemann-Liouville operator, -operator, and Atangana-Baleanu fractional analysis, the examined equation-which consists of the normalized electric field of the Langmuir oscillation and normalized density perturbation-is thoroughly examined.

View Article and Find Full Text PDF

Purpose: To evaluate effects and related factors of short-time accommodation training on measuring consistency of InnovEyes Sitemap (Alcon/WaveLight; Alcon Laboratories, Inc), NIDEK ARK-1 autorefractor (Nidek Corporation), and subjective refraction (SR).

Methods: One hundred adults (100 eyes) with myopia aged 17 to 40 years were enrolled. Refraction was obtained by InnovEyes Sitemap, autorefraction, and SR in a randomized order.

View Article and Find Full Text PDF

International consensus on fasting terminology.

Cell Metab

August 2024

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, 14109 Berlin, Germany.

Although fasting is increasingly applied for disease prevention and treatment, consensus on terminology is lacking. Using Delphi methodology, an international, multidisciplinary panel of researchers and clinicians standardized definitions of various fasting approaches in humans. Five online surveys and a live online conference were conducted with 38 experts, 25 of whom completed all 5 surveys.

View Article and Find Full Text PDF
Article Synopsis
  • Undifferentiated small round-cell sarcomas (uSRCSs) are a tricky type of cancer to diagnose and treat, with no specific treatments available for advanced cases.
  • A 37-year-old woman with advanced uSRCS tried several treatments that didn't work, including chemotherapy and a combination of other drugs.
  • Finally, she responded well to a new treatment combining surufatinib and camrelizumab after many earlier treatments failed.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!